Iowa City, IA, United States of America

Mengshi Li

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Mengshi Li

Introduction

Mengshi Li is a prominent inventor based in Iowa City, IA, known for his significant contributions to the field of cancer therapy and metal chelation. With a total of four patents to his name, he has made strides in developing innovative methods that enhance therapeutic performance and efficiency.

Latest Patents

Among his latest patents is a structural optimization method aimed at improving the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers. This invention provides a carcinoma-targeting conjugate that enhances the effectiveness of cancer treatments. Another notable patent involves compositions for chelating metals at low temperatures. This method describes a chelating reaction that occurs at temperatures below about 40° C, utilizing specific compounds to form a chelated composition.

Career Highlights

Mengshi Li is affiliated with the University of Iowa Research Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving therapeutic techniques and methodologies in the medical field.

Collaborations

He collaborates with esteemed colleagues, including Michael K Schultz and Dongyoul Lee, who contribute to his research endeavors and enhance the impact of his inventions.

Conclusion

Mengshi Li's innovative work in cancer therapy and metal chelation exemplifies the importance of research and development in improving medical treatments. His contributions are paving the way for advancements in therapeutic techniques that can significantly benefit patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…